Safety and efficacy of peptide receptor radionuclide therapy in treating high-risk patients with extensive neuroendocrine tumors

被引：0
|
作者：
Alsadik, S. R. [1 ]
Gnanasegaran, G. [1 ]
Chen, L. [1 ]
Toumpanakis, C. [1 ]
Caplin, M. [1 ]
Navalkissoor, S. [1 ]
机构：
[1] Royal Free Hosp, London, England
来源：
JOURNAL OF NEUROENDOCRINOLOGY | 2021年 / 33卷
关键词：
neuroendocrine tumor; net; peptide receptor radionuclide therapy prrt; 1771u-dotatate; extensive liver metastases; extensive skeletal metastases; extensive tumor burden;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
K05
引用
收藏
页码：172 / 172
页数：1
相关论文
共 50 条
  • [1] Safety and efficacy of peptide receptor radionuclide therapy with 177Lu-DOTA-EB-TATE in patients with metastatic neuroendocrine tumors
    Jiang, Yuanyuan
    Liu, Qingxing
    Wang, Guochang
    Sui, Huimin
    Wang, Rongxi
    Wang, Jiarou
    Zhang, Jingjing
    Zhu, Zhaohui
    Chen, Xiaoyuan
    THERANOSTICS, 2022, 12 (15): : 6437 - 6445
  • [2] Safety and Efficacy of Peptide Receptor Radionuclide Therapy (PRRT) Following Bland Embolization for Metastatic Neuroendocrine Tumors
    Alayli, Adam
    Ngo, Hoang
    Sikaria, Dhiraj
    Ahmed, Altan
    Salloum, Elias
    Strosberg, Jonathan R.
    Al-Toubah, Taymeyah E.
    Kis, Bela
    Haider, Mintallah
    El-Haddad, Ghassan
    CANCERS, 2024, 16 (15)
  • [3] Real-world efficacy of lutetium peptide receptor radionuclide therapy in patients with neuroendocrine tumors
    Almeamar, H.
    Cullen, L.
    Murphy, D.
    Crowley, R.
    Skehan, S.
    Welin, S.
    O'Shea, D.
    O'Toole, D.
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 136 - 136
  • [4] Peptide Receptor Radionuclide Therapy Combined With Chemotherapy in Patients With Neuroendocrine Tumors
    Yordanova, Anna
    Ahrens, Harriet
    Feldmann, Georg
    Brossart, Peter
    Gaertner, Florian C.
    Fottner, Christian
    Weber, Matthias M.
    Ahmadzadehfar, Hojjat
    Schreckenberger, Mathias
    Miederer, Matthias
    Essler, Markus
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (05) : E329 - E335
  • [5] Peptide Receptor Radionuclide Therapy in the Treatment of Neuroendocrine Tumors
    Kwekkeboom, Dik J.
    Krenning, Eric P.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 30 (01) : 179 - +
  • [6] Clinical Efficacy of Peptide Receptor Radionuclide Therapy in Patients with Neuroendocrine Neoplasm
    Zacho, M. D.
    Iversen, P.
    Villadsen, G. E.
    Arveschoug, A. K.
    Grembwk, H.
    Dam, G.
    NEUROENDOCRINOLOGY, 2020, 110 : 279 - 279
  • [7] The Safety and Efficacy of Peptide Receptor Radionuclide Therapy for Gastro-Entero-Pancreatic Neuroendocrine Tumors: A Single Center Experience
    Piscopo, Leandra
    Zampella, Emilia
    Volpe, Fabio
    Gaudieri, Valeria
    Nappi, Carmela
    Di Donna, Erica
    Clemente, Stefania
    Varallo, Antonio
    Scaglione, Mariano
    Cuocolo, Alberto
    Klain, Michele
    CURRENT ONCOLOGY, 2024, 31 (09) : 5617 - 5629
  • [8] Efficacy of 177Lu Peptide Receptor Radionuclide Therapy for the Treatment of Neuroendocrine Tumors A Meta-analysis
    Saravana-Bawan, Bianka
    Bajwa, Amandeep
    Paterson, John
    McEwan, Alexander J. B.
    McMullen, Todd P. W.
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (09) : 719 - 727
  • [9] Retrospective study of peptide receptor radionuclide therapy for Japanese patients with advanced neuroendocrine tumors
    Kobayashi, Noritoshi
    Wild, Damian
    Kaul, Felix
    Shimamura, Takeshi
    Takano, Shoko
    Takeda, Yuma
    Okubo, Naoki
    Suzuki, Akihiro
    Tokuhisa, Motohiko
    Ichikawa, Yasushi
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2021, 28 (09) : 727 - 739
  • [10] Peptide receptor radionuclide therapy for treatment of metastatic neuroendocrine tumors in children
    Foster, Jennifer H.
    Sher, Andrew
    Seghers, Victor
    Poston, Jay
    Wells, Donald
    Delpassand, Ebrahim S.
    Potter, Samara
    Mahajan, Priya
    Venkatramani, Rajkumar
    PEDIATRIC BLOOD & CANCER, 2021, 68 (07)
12345